d'Sylva Paul

Commonwealth Biotechnologies Inc.

Director

Avg. Two Year Performance

(91%) Avg. Purchase Return (38%) Compound

94% Avg. Sale Return 39% Compound

Holdings: 271.22K shares

Last Three Months: 23-Aug-24 -- 22-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Research Services

Diversified Services

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions